Fundraising Overview - Jiangsu Kangzhong Digital Medical Technology Co., Ltd. raised a total of RMB 511,368,684.97 through the issuance of 22,032,257 shares at a price of RMB 23.21 per share, with a net amount of RMB 447,342,486.13 after deducting issuance costs [1] - As of June 30, 2025, the company has accumulated interest income of RMB 4,418,226.16 and received investment income of RMB 24,965,294.32, totaling RMB 29,383,520.48 [1] Fund Utilization - The company has spent RMB 310,088,509.94 on fundraising projects, with RMB 21,493,944.94 spent in the current year [1] - The remaining balance in the fundraising account as of June 30, 2025, is RMB 64,994,315.57 [1] Fund Management - The company has established a fundraising management system to ensure the proper use and storage of funds, adhering to relevant laws and regulations [1] - A tripartite supervision agreement has been signed with banks and the sponsor to ensure dedicated use of the funds [1] Cash Management - The company has approved the use of up to RMB 150 million of idle fundraising for cash management, with a usage period from the approval date until the next annual board meeting in 2025 [2] - The company has invested idle funds in short-term financial products with a maturity of less than 12 months [2] Project Status - The company has not changed the use of fundraising projects or transferred any projects during the reporting period [2] - The company has experienced delays in the construction of the flat panel detector production base and R&D service center, with completion dates extended to December 2025 due to various unforeseen factors [3]
康众医疗: 康众医疗2025年半年度募集资金存放与使用情况的专项报告